Loading data
CLDXNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.55 m USD | 7.02 m USD | 6.88 m USD | 2.36 m USD | 4.65 m USD |
| Cost of revenue | 200 k USD | 200 k USD | 300 k USD | 100 k USD | 100 k USD |
| Research and development expense | 245.07 m USD | 163.55 m USD | 118.01 m USD | 82.26 m USD | 53.31 m USD |
| Operating profit | -287.37 m USD | -195.08 m USD | -154.54 m USD | -115.23 m USD | -71.24 m USD |
| Profit before tax | -258.76 m USD | -157.86 m USD | -141.43 m USD | -112.33 m USD | -70.74 m USD |
| Income tax expense | — | — | — | — | -200 k USD |
| Net income (reported basis) | -258.76 m USD | -157.86 m USD | -141.43 m USD | -112.33 m USD | -70.51 m USD |
| Net income attributable to common shareholders | -258.76 m USD | -157.86 m USD | -141.43 m USD | -112.33 m USD | -70.51 m USD |
| Basic earnings per share | -3.9 USD/share | -2.45 USD/share | -2.92 USD/share | -2.4 USD/share | -1.64 USD/share |
| Diluted earnings per share | -3.9 USD/share | -2.45 USD/share | -2.92 USD/share | -2.4 USD/share | -1.64 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.